This cross-sectional study investigates the number of US Food and Drug Administration–approved cancer drugs that displaced standard-of-care therapies between 2016 and 2021. Click to show full abstract
This cross-sectional study investigates the number of US Food and Drug Administration–approved cancer drugs that displaced standard-of-care therapies between 2016 and 2021.
               
Click one of the above tabs to view related content.